Pelage Pharmaceuticals, Inc. is a biotechnology company developing novel drugs to promote hair health.
Market:Currently, 400 million people, both men and women, suffer from Alopecia worldwide. There are only two FDA-approved medications for treating non-scarring Alopecia, Propecia and Rogaine (Minoxidil). Propecia is associated with adverse side effects and neither drug is very effective. More than $7 billion is being spent on hair loss treatments annually.
Technology:Pelage’s proprietary small molecules are the first to target hair follicle stem cell metabolism causing their activation.
- Activates quiescent hair follicle stem cells
- Small molecules access the hair follicles when applies to the scalp
- No need for implants, injections or oral treatments